Syngene International Ltd
NSE :SYNGENE BSE :539268 Sector : HealthcareBuy, Sell or Hold SYNGENE? Ask The Analyst
BSE
prev close
OPEN PRICE
volume
Today's low / high
52 WK low / high
bid price (qty)
offer price (qty)
NSE
prev close
open price
volume
Today's' low / high
52 WK low / high
bid price (qty)
offer price (qty)
25 Mar 714.25 (-0.81%) | 24 Mar 720.10 (0.57%) | 21 Mar 716.00 (1.64%) | 20 Mar 704.45 (-0.23%) | 19 Mar 706.05 (3.41%) | 18 Mar 682.80 (1.13%) | 17 Mar 675.15 (1.34%) | 13 Mar 666.20 (-1.54%) | 12 Mar 676.60 (-0.76%) | 11 Mar 681.80 (0.61%) | 10 Mar 677.65 (-0.29%) | 07 Mar 679.65 (-1.29%) | 06 Mar 688.55 (1.67%) | 05 Mar 677.25 (3.52%) | 04 Mar 654.20 (0.41%) | 03 Mar 651.55 (-0.13%) | 28 Feb 652.40 (-3.68%) | 27 Feb 677.30 (-1.68%) | 25 Feb 688.90 (-1.70%) | 24 Feb 700.80 (-1.81%) | 21 Feb 713.75 (-0.12%) |
Technical Analysis
Short Term Investors

Very Bullish
Medium Term Investors

Bearish
Long Term Investors

Very Bearish
Moving Averages
5 DMA
Bullish
711.89
10 DMA
Bullish
694.13
20 DMA
Bullish
684.34
50 DMA
Bearish
728.46
100 DMA
Bearish
802.92
200 DMA
Bearish
810.68
Intraday Support and Resistance
(Based on Pivot Points) undefined |
Updated On Mar 25, 2025 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 772.89 | 758.72 | 724.26 | - | - |
R2 | 758.72 | 744.82 | 720.92 | 756.7 | - |
R1 | 736.49 | 736.22 | 717.59 | 732.45 | 747.6 |
P | 722.32 | 722.32 | 722.32 | 720.3 | 727.88 |
S1 | 700.09 | 708.42 | 710.91 | 696.05 | 711.2 |
S2 | 685.92 | 699.82 | 707.58 | 683.9 | - |
S3 | 663.69 | 685.92 | 704.24 | - | - |
Key Metrics
EPS
11.41
P/E
62.59
P/B
6.66
Dividend Yield
0.17%
Market Cap
28,751 Cr.
Face Value
10
Book Value
107.28
ROE
12.95%
EBITDA Growth
300.9 Cr.
Debt/Equity
0.17
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Syngene International Ltd Quaterly Results
Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | ||
INCOME | 882.8 | 933 | 839.8 | 907.5 | 962 | |
PROFIT | 114.49 | 188.6 | 51.79 | 106.1 | 131.1 | |
EPS | 2.78 | 4.7 | 1.89 | 2.64 | 3.27 |
Syngene International Ltd Quaterly Results
Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | ||
INCOME | 820.7 | 880 | 776.2 | 837.7 | 895.1 | |
PROFIT | 102.76 | 189.8 | 49.96 | 96.6 | 123.1 | |
EPS | 2.49 | 4.73 | 1.84 | 2.41 | 3.07 |
Profit & Loss (Figures in Rs. Crores)
Syngene International Ltd Profit & Loss
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 1498.4 | 1874.7 | 2164 | 2309.1 | 2678.6 | 3305.8 | 3522.6 | |
PROFIT | 289.35 | 328.12 | 358.49 | 379.76 | 417.63 | 470.41 | 520.91 | |
EPS | 7.64 | 8.29 | 10.3 | 10.12 | 9.88 | 11.57 | 12.69 |
Syngene International Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 881.9 | 1117.7 | 1293.9 | 1498.4 | 1874.7 | 2164 | 2304.2 | 2730.6 | 3306.4 | 3234.5 | |
PROFIT | 175 | 240.8 | 286.74 | 289.05 | 327.22 | 357.85 | 378.54 | 415.64 | 470.5 | 466.99 | |
EPS | 7.82 | 5.92 | 7.19 | 7.63 | 8.27 | 10.29 | 10.09 | 9.83 | 11.78 | 11.6 |
Balance Sheet (Figures in Rs. Crores)
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | |
SOURCES OF FUNDS : | |||||||
Share Capital | 402 | 401.4 | 400.8 | 400 | 400 | 200 | 200 |
Reserves Total | 3,855.8 | 3,216.6 | 2,896.8 | 2,421.4 | 1,775.8 | 1,768.4 | 1,520.4 |
Total Shareholders Funds | 4,257.8 | 3,618 | 3,297.6 | 2,821.4 | 2,175.8 | 1,968.4 | 1,720.4 |
Secured Loans | 141.7 | 575.3 | 531.5 | 512.4 | 376.7 | 606.6 | 692.6 |
Unsecured Loans | 413.5 | 239.9 | 490.1 | 380.5 | 396.2 | 206.7 | 94.8 |
Total Debt | 555.2 | 815.2 | 1,021.6 | 892.9 | 772.9 | 813.3 | 787.4 |
Other Liabilities | 284.5 | 321.6 | 295.6 | 311.2 | 366.7 | 244.8 | 99.5 |
Total Liabilities | 5,097.5 | 4,754.8 | 4,614.8 | 4,025.5 | 3,315.4 | 3,026.5 | 2,607.3 |
APPLICATION OF FUNDS : | |||||||
Gross Block | 5,011.6 | 4,546.9 | 3,943.5 | 3,460 | 3,017.2 | 2,171 | 1,660.7 |
Less: Accumulated Depreciation | 2,161.6 | 1,880 | 1,550.7 | 1,259 | 997.5 | 794.2 | 630.3 |
Net Block | 2,850 | 2,666.9 | 2,392.8 | 2,201 | 2,019.7 | 1,376.8 | 1,030.4 |
Capital Work in Progress | 838.1 | 176.9 | 346.4 | 237.2 | 234.1 | 273.7 | 155.4 |
Investments | 547.9 | 918.5 | 1,034.1 | 702 | 776.4 | 716 | 157.7 |
Inventories | 238.5 | 332.8 | 179.4 | 59.6 | 25.2 | 43.4 | 86 |
Sundry Debtors | 441.6 | 529.3 | 507.7 | 475.7 | 398.2 | 338.7 | 266.8 |
Cash and Bank Balance | 563.5 | 531.7 | 517.9 | 642.6 | 281.5 | 436.9 | 967.4 |
Loans and Advances | 202.2 | 207.1 | 237.1 | 205.5 | 169.3 | 229.1 | 242.3 |
Total Current Assets | 1,445.8 | 1,600.9 | 1,442.1 | 1,383.4 | 874.2 | 1,048.1 | 1,562.5 |
Current Liabilities | 933.8 | 1,010.5 | 866.8 | 797.8 | 794.3 | 640.2 | 555.4 |
Provisions | 120.3 | 65.7 | 82.2 | 59.9 | 53.2 | 36.8 | 26.3 |
Total Current Liabilities & Provisions | 1,054.1 | 1,076.2 | 949 | 857.7 | 847.5 | 677 | 581.7 |
Net Current Assets | 391.7 | 524.7 | 493.1 | 525.7 | 26.7 | 371.1 | 980.8 |
Deferred Tax Assets | 182.6 | 194.1 | 190.7 | 188.9 | 208.3 | 124.6 | 118.4 |
Deferred Tax Liability | 141.9 | 124.5 | 125.1 | 99.8 | 85.6 | 33.1 | 46 |
Net Deferred Tax | 40.7 | 69.6 | 65.6 | 89.1 | 122.7 | 91.5 | 72.4 |
Other Assets | 429.1 | 398.2 | 282.8 | 270.5 | 135.8 | 197.4 | 210.6 |
Total Assets | 5,097.5 | 4,754.8 | 4,614.8 | 4,025.5 | 3,315.4 | 3,026.5 | 2,607.3 |
Contingent Liabilities | 1,269.2 | 1,243.8 | 1,095.6 | 859.6 | 424.7 | 335.9 | 476.8 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 402 | 401.4 | 400.8 | 400 | 400 | 200 | 200 | 200 | 200 | 199.1 |
Reserves Total | 3,789.5 | 3,217.5 | 2,891.2 | 2,418.3 | 1,774.1 | 1,767.2 | 1,520.1 | 1,224.4 | 824.7 | 645.8 |
Equity Application Money | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -11.3 | 0 | 0 |
Total Shareholders Funds | 4,191.5 | 3,618.9 | 3,292 | 2,818.3 | 2,174.1 | 1,967.2 | 1,720.1 | 1,413.1 | 1,024.7 | 844.9 |
Secured Loans | 141.7 | 575.3 | 531.5 | 512.4 | 376.7 | 606.6 | 692.6 | 689.8 | 891 | 18.6 |
Unsecured Loans | 190.7 | 63.3 | 490.1 | 380.5 | 396.2 | 206.7 | 94.8 | 116.6 | 0 | 136.4 |
Total Debt | 332.4 | 638.6 | 1,021.6 | 892.9 | 772.9 | 813.3 | 787.4 | 806.4 | 891 | 155 |
Other Liabilities | 281.9 | 319.6 | 295.6 | 311.2 | 366.7 | 244.8 | 99.5 | 71.6 | 71.6 | 77.9 |
Total Liabilities | 4,805.8 | 4,577.1 | 4,609.2 | 4,022.4 | 3,313.7 | 3,025.3 | 2,607 | 2,291.1 | 1,987.3 | 1,077.8 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 4,371 | 4,070.7 | 3,943.5 | 3,460 | 3,017.2 | 2,171 | 1,660.7 | 1,331.9 | 1,111.4 | 938 |
Less : Accumulated Depreciation | 2,053.1 | 1,810.8 | 1,550.7 | 1,259 | 997.5 | 794.2 | 630.3 | 521.5 | 531.2 | 434.7 |
Net Block | 2,317.9 | 2,259.9 | 2,392.8 | 2,201 | 2,019.7 | 1,376.8 | 1,030.4 | 810.4 | 580.2 | 503.3 |
Capital Work in Progress | 759.6 | 126.2 | 346.4 | 237.2 | 234.1 | 273.7 | 155.4 | 174.9 | 236.8 | 105.1 |
Investments | 927.6 | 940.8 | 1,034.4 | 702.3 | 776.7 | 716.3 | 158 | 540.4 | 276.6 | 146 |
Inventories | 234 | 332.8 | 179.4 | 59.6 | 25.2 | 43.4 | 86 | 32.2 | 37.7 | 38.4 |
Sundry Debtors | 427.5 | 484.4 | 508.2 | 474.4 | 398.2 | 338.7 | 266.8 | 198.7 | 185.2 | 179.9 |
Cash and Bank Balance | 528.2 | 509.3 | 515.1 | 638.2 | 280.3 | 435.4 | 966.5 | 527.3 | 719.9 | 115.7 |
Loans and Advances | 169.6 | 733.4 | 237.1 | 205.5 | 169.3 | 229.1 | 242.3 | 225.5 | 115.3 | 105.8 |
Total Current Assets | 1,359.3 | 2,059.9 | 1,439.8 | 1,377.7 | 873 | 1,046.6 | 1,561.6 | 983.7 | 1,058.1 | 439.8 |
Current Liabilities | 914.1 | 1,210.1 | 869.4 | 795.3 | 795.1 | 640.2 | 555.2 | 462.5 | 350.8 | 329.4 |
Provisions | 114 | 60.8 | 82.2 | 59.8 | 53.2 | 36.8 | 26.2 | 21.2 | 17.4 | 9.4 |
Total Current Liabilities & Provisions | 1,028.1 | 1,270.9 | 951.6 | 855.1 | 848.3 | 677 | 581.4 | 483.7 | 368.2 | 338.8 |
Net Current Assets | 331.2 | 789 | 488.2 | 522.6 | 24.7 | 369.6 | 980.2 | 500 | 689.9 | 101 |
Deferred Tax Assets | 178.3 | 201.6 | 190.3 | 188.5 | 208.3 | 124.6 | 118.4 | 97.2 | 84.5 | 5.1 |
Deferred Tax Liability | 128.5 | 122.1 | 125.2 | 99.8 | 85.6 | 33.1 | 46 | 33.5 | 12.8 | 10 |
Net Deferred Tax | 49.8 | 79.5 | 65.1 | 88.7 | 122.7 | 91.5 | 72.4 | 63.7 | 71.7 | -4.9 |
Other Assets | 419.7 | 381.7 | 282.3 | 270.6 | 135.8 | 197.4 | 210.6 | 201.7 | 132.1 | 227.3 |
Total Assets | 4,805.8 | 4,577.1 | 4,609.2 | 4,022.4 | 3,313.7 | 3,025.3 | 2,607 | 2,291.1 | 1,987.3 | 1,077.8 |
Contingent Liabilities | 1,264.2 | 1,243.8 | 547.8 | 859.6 | 849.2 | 671.6 | 238.5 | 376.6 | 384.9 | 110.4 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 510 |
Depreciation | 425.9 |
Interest (Net) | -15.2 |
P/L on Sales of Invest | -14.4 |
Prov. and W/O (Net) | -14.8 |
P/L in Forex | -3.6 |
Total Adjustments (PBT and Ext... | 475.9 |
Operating Profit before Workin... | 985.9 |
Trade and 0ther Receivables | 86.7 |
Inventories | 114.6 |
Trade Payables | -102.7 |
Total Adjustments (OP before W... | 181.3 |
Cash Generated from/(used in) ... | 1,167.2 |
Direct Taxes Paid | -125.1 |
Total Adjustments(Cash Generat... | -125.1 |
Cash Flow before Extraordinary... | 1,042.1 |
Net Cash from Operating Activi... | 1,042.1 |
Purchased of Fixed Assets | -510.8 |
Sale of Fixed Assets | 22.1 |
Purchase of Investments | -2,804 |
Sale of Investments | 2,735.2 |
Interest Received | 81.5 |
Net Cash used in Investing Act... | -494.4 |
Of the Long Tem Borrowings | -390.4 |
Of the Short Term Borrowings | -45.2 |
Of Financial Liabilities | -36.8 |
Dividend Paid | -50.3 |
Interest Paid | -28.8 |
Net Cash used in Financing Act... | -551.5 |
Net Profit before Tax and Extr... | 466.5 |
Depreciation | 368.9 |
Interest (Net) | -31.6 |
P/L on Sales of Invest | -13 |
Prov. and W/O (Net) | -17.8 |
P/L in Forex | -3.3 |
Total Adjustments (PBT and Ext... | 380 |
Operating Profit before Workin... | 846.5 |
Trade and 0ther Receivables | 58.8 |
Inventories | 119.1 |
Trade Payables | -116.6 |
Total Adjustments (OP before W... | 165.3 |
Cash Generated from/(used in) ... | 1,011.8 |
Direct Taxes Paid | -98.4 |
Total Adjustments(Cash Generat... | -98.4 |
Cash Flow before Extraordinary... | 913.4 |
Net Cash from Operating Activi... | 913.4 |
Purchased of Fixed Assets | -367.2 |
Sale of Fixed Assets | 21.6 |
Purchase of Investments | -2,944 |
Sale of Investments | 2,516.4 |
Interest Received | 81.2 |
Net Cash used in Investing Act... | -382.6 |
Of the Long Tem Borrowings | -390.4 |
Of the Short Term Borrowings | -45.2 |
Of Financial Liabilities | -32.2 |
Dividend Paid | -50.3 |
Interest Paid | -18.2 |
Net Cash used in Financing Act... | -536.3 |
Company Details
Registered Office |
|
Address | Biocon SEZ Biocon Park, Plot No 2 & 3 Bommasandra Inds |
City | Bengaluru |
State | Karnataka |
Pin Code | 560099 |
Tel. No. | 91-80-68915000/67758781 |
Fax. No. | 91-80-28083189 |
investor@syngeneintl.com; Mayank.Verma@syngeneintl | |
Internet | http://www.syngeneintl.com |
Registrars |
|
Address | Biocon SEZ Biocon Park |
City | Bengaluru |
State | Karnataka |
Pin Code | 560099 |
Tel. No. | 91-80-68915000/67758781 |
Fax. No. | 91-80-28083189 |
investor@syngeneintl.com; Mayank.Verma@syngeneintl | |
Internet | http://www.syngeneintl.com |
Management |
|
Name | Designation |
Kiran Mazumdar Shaw | Chairperson |
Catherine Patricia Rosenberg | Non Executive Director |
Paul Frederick Blackburn | Independent Director |
Vijay Kuchroo | Independent Director |
Jonathan Hunt | Managing Director & CEO |
Vinita Bali | Lead Independent Director |
Priyadarshnini Mahapatra | Company Sec. & Compli. Officer |
Sharmila Karve | Independent Director |
Kush Parmar | Independent Director |
SIBAJI BISWAS | Executive Director & CFO |
Nilanjan Roy | Independent Director |
Manja Boerman | Independent Director |